Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma

This study has been completed.
Information provided by (Responsible Party):
MedImmune LLC Identifier:
First received: July 23, 2009
Last updated: November 11, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)